Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 180

1.

Dementia spectrum disorders: lessons learnt from decades with PET research.

Wilson H, Pagano G, Politis M.

J Neural Transm (Vienna). 2019 Feb 14. doi: 10.1007/s00702-019-01975-4. [Epub ahead of print] Review.

PMID:
30762136
2.

Cortical thinning across Parkinson's disease stages and clinical correlates.

Wilson H, Niccolini F, Pellicano C, Politis M.

J Neurol Sci. 2019 Jan 17;398:31-38. doi: 10.1016/j.jns.2019.01.020. [Epub ahead of print]

PMID:
30682518
3.

Preface.

Politis M.

Int Rev Neurobiol. 2019;144:xiii. doi: 10.1016/S0074-7742(19)30009-1. No abstract available.

PMID:
30638459
4.

Molecular Imaging of Dementia With Lewy Bodies.

Cousins O, Yousaf T, Wilson H, Pagano G, Politis M.

Int Rev Neurobiol. 2019;144:59-93. doi: 10.1016/bs.irn.2018.10.007. Epub 2018 Nov 28.

PMID:
30638457
5.

Hybrid PET-MRI Applications in Movement Disorders.

Tondo G, Esposito M, Dervenoulas G, Wilson H, Politis M, Pagano G.

Int Rev Neurobiol. 2019;144:211-257. doi: 10.1016/bs.irn.2018.10.003. Epub 2018 Nov 8.

PMID:
30638455
6.

Imaging Markers of Progression in Parkinson's Disease.

Strafella AP, Bohnen NI, Pavese N, Vaillancourt DE, van Eimeren T, Politis M, Tessitore A, Ghadery C, Lewis S; IPMDS‐Neuroimaging Study Group.

Mov Disord Clin Pract. 2018 Oct 9;5(6):586-596. doi: 10.1002/mdc3.12673. eCollection 2018 Nov-Dec. Review.

PMID:
30637278
7.

Preface.

Politis M.

Int Rev Neurobiol. 2018;143:ix-x. doi: 10.1016/S0074-7742(18)30162-4. No abstract available.

PMID:
30473199
8.

Imaging Transplantation in Movement Disorders.

de Natale ER, Wilson H, Pagano G, Politis M.

Int Rev Neurobiol. 2018;143:213-263. doi: 10.1016/bs.irn.2018.10.002. Epub 2018 Nov 3.

PMID:
30473196
9.

Preface.

Politis M.

Int Rev Neurobiol. 2018;142:xi-xii. doi: 10.1016/S0074-7742(18)30146-6. No abstract available.

PMID:
30409262
10.

Structural Magnetic Resonance Imaging in Huntington's Disease.

Wilson H, Dervenoulas G, Politis M.

Int Rev Neurobiol. 2018;142:335-380. doi: 10.1016/bs.irn.2018.09.006. Epub 2018 Oct 8.

PMID:
30409258
11.

Molecular Imaging in Huntington's Disease.

Wilson H, Politis M.

Int Rev Neurobiol. 2018;142:289-333. doi: 10.1016/bs.irn.2018.08.007. Epub 2018 Aug 29.

PMID:
30409256
12.

PDE10A and ADCY5 mutations linked to molecular and microstructural basal ganglia pathology.

Niccolini F, Mencacci NE, Yousaf T, Rabiner EA, Salpietro V, Pagano G, Balint B, Efthymiou S, Houlden H, Gunn RN, Wood N, Bhatia KP, Politis M.

Mov Disord. 2018 Dec;33(12):1961-1965. doi: 10.1002/mds.27523. Epub 2018 Oct 21.

PMID:
30345538
13.

Neuroimaging of Sleep Disturbances in Movement Disorders.

Yousaf T, Pagano G, Wilson H, Politis M.

Front Neurol. 2018 Sep 11;9:767. doi: 10.3389/fneur.2018.00767. eCollection 2018. Review.

14.

Preface.

Politis M.

Int Rev Neurobiol. 2018;141:xv-xvi. doi: 10.1016/S0074-7742(18)30122-3. No abstract available.

PMID:
30314609
15.

Advances in MRI Methodology.

Yousaf T, Dervenoulas G, Politis M.

Int Rev Neurobiol. 2018;141:31-76. doi: 10.1016/bs.irn.2018.08.008. Epub 2018 Sep 14.

PMID:
30314602
16.

Molecular Imaging of the Serotonergic System in Parkinson's Disease.

Pagano G, Politis M.

Int Rev Neurobiol. 2018;141:173-210. doi: 10.1016/bs.irn.2018.08.002. Epub 2018 Sep 6.

PMID:
30314596
17.

Molecular Imaging of the Dopaminergic System in Idiopathic Parkinson's Disease.

de Natale ER, Niccolini F, Wilson H, Politis M.

Int Rev Neurobiol. 2018;141:131-172. doi: 10.1016/bs.irn.2018.08.003. Epub 2018 Sep 6.

PMID:
30314595
18.

Magnetic resonance imaging in Alzheimer's disease and mild cognitive impairment.

Chandra A, Dervenoulas G, Politis M; Alzheimer’s Disease Neuroimaging Initiative.

J Neurol. 2018 Aug 17. doi: 10.1007/s00415-018-9016-3. [Epub ahead of print] Review.

PMID:
30120563
19.

Disease-related patterns of in vivo pathology in Corticobasal syndrome.

Niccolini F, Wilson H, Hirschbichler S, Yousaf T, Pagano G, Whittington A, Caminiti SP, Erro R, Holton JL, Jaunmuktane Z, Esposito M, Martino D, Abdul A, Passchier J, Rabiner EA, Gunn RN, Bhatia KP, Politis M; Alzheimer’s Disease Neuroimaging Initiative.

Eur J Nucl Med Mol Imaging. 2018 Dec;45(13):2413-2425. doi: 10.1007/s00259-018-4104-2. Epub 2018 Aug 8.

20.

REM behavior disorder predicts motor progression and cognitive decline in Parkinson disease.

Pagano G, De Micco R, Yousaf T, Wilson H, Chandra A, Politis M.

Neurology. 2018 Sep 4;91(10):e894-e905. doi: 10.1212/WNL.0000000000006134. Epub 2018 Aug 8.

PMID:
30089615
21.

Proton Collision on Deoxyribose Originating from Doubly Ionized Water Molecule Dissociation.

Hervé du Penhoat MA, Moraga NRG, Gaigeot MP, Vuilleumier R, Tavernelli I, Politis MF.

J Phys Chem A. 2018 Jun 21;122(24):5311-5320. doi: 10.1021/acs.jpca.8b04787. Epub 2018 Jun 11.

PMID:
29846073
22.

Serotonergic dysregulation is linked to sleep problems in Parkinson's disease.

Wilson H, Giordano B, Turkheimer FE, Chaudhuri KR, Politis M.

Neuroimage Clin. 2018 Mar 2;18:630-637. doi: 10.1016/j.nicl.2018.03.001. eCollection 2018.

23.

Neuroimaging in Lewy body dementia.

Yousaf T, Dervenoulas G, Valkimadi PE, Politis M.

J Neurol. 2019 Jan;266(1):1-26. doi: 10.1007/s00415-018-8892-x. Epub 2018 May 14. Review.

24.

Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson's disease.

Schulz J, Pagano G, Fernández Bonfante JA, Wilson H, Politis M.

Brain. 2018 May 1;141(5):1501-1516. doi: 10.1093/brain/awy072.

25.

Cerebral serotonin transporter measurements with [11C]DASB: A review on acquisition and preprocessing across 21 PET centres.

Nørgaard M, Ganz M, Svarer C, Feng L, Ichise M, Lanzenberger R, Lubberink M, Parsey RV, Politis M, Rabiner EA, Slifstein M, Sossi V, Suhara T, Talbot PS, Turkheimer F, Strother SC, Knudsen GM.

J Cereb Blood Flow Metab. 2018 Apr 13:271678X18770107. doi: 10.1177/0271678X18770107. [Epub ahead of print]

PMID:
29651896
26.

Diabetes mellitus and Parkinson disease.

Pagano G, Polychronis S, Wilson H, Giordano B, Ferrara N, Niccolini F, Politis M.

Neurology. 2018 May 8;90(19):e1654-e1662. doi: 10.1212/WNL.0000000000005475. Epub 2018 Apr 6.

PMID:
29626177
27.

Excessive daytime sleepiness may be associated with caudate denervation in Parkinson disease.

Yousaf T, Pagano G, Niccolini F, Politis M.

J Neurol Sci. 2018 Apr 15;387:220-227. doi: 10.1016/j.jns.2018.02.032. Epub 2018 Feb 21.

PMID:
29571867
28.

Increased dopaminergic function in the thalamus is associated with excessive daytime sleepiness.

Yousaf T, Pagano G, Niccolini F, Politis M.

Sleep Med. 2018 Mar;43:25-30. doi: 10.1016/j.sleep.2017.11.1137. Epub 2017 Dec 12.

PMID:
29482807
29.

Dopamine reuptake transporter-single-photon emission computed tomography and transcranial sonography as imaging markers of prediagnostic Parkinson's disease.

Noyce AJ, Dickson J, Rees RN, Bestwick JP, Isaias IU, Politis M, Giovannoni G, Warner TT, Lees AJ, Schrag A.

Mov Disord. 2018 Mar;33(3):478-482. doi: 10.1002/mds.27282. Epub 2018 Jan 30.

PMID:
29380907
30.

Roles of Hydration for Inducing Decomposition of 2-Deoxy-d-ribose by Ionization of Oxygen K-Shell Electrons.

Fujii K, Izumi Y, Narita A, Ghose KK, López-Tarifa P, Touati A, Spezia R, Vuilleumier R, Gaigeot MP, Politis MF, Du Penhoat MH, Yokoya A.

Radiat Res. 2018 Mar;189(3):264-272. doi: 10.1667/RR14225.1. Epub 2018 Jan 8.

PMID:
29309265
31.

The serotonergic system in Parkinson's patients with dyskinesia: evidence from imaging studies.

Pagano G, Niccolini F, Politis M.

J Neural Transm (Vienna). 2018 Aug;125(8):1217-1223. doi: 10.1007/s00702-017-1823-7. Epub 2017 Dec 20. Review.

32.

Be vigilant for dementia in Parkinson’s disease.

Niccolini F, Diamantopoulos K, Kiosses S, Politis M.

Practitioner. 2017 May;261(1804):11-5. Review.

PMID:
29120562
33.

11 C-PE2I and 18 F-Dopa PET for assessing progression rate in Parkinson's: A longitudinal study.

Li W, Lao-Kaim NP, Roussakis AA, Martín-Bastida A, Valle-Guzman N, Paul G, Loane C, Widner H, Politis M, Foltynie T, Barker RA, Piccini P.

Mov Disord. 2018 Jan;33(1):117-127. doi: 10.1002/mds.27183. Epub 2017 Oct 30.

34.

Constipation is not associated with dopamine transporter pathology in early drug-naïve patients with Parkinson's disease.

Pagano G, Yousaf T, Wilson H, Niccolini F, Polychronis S, Chaudhuri KR, Politis M.

Eur J Neurol. 2018 Feb;25(2):307-312. doi: 10.1111/ene.13503. Epub 2017 Dec 11.

PMID:
29078029
35.

PET Molecular Imaging Research of Levodopa-Induced Dyskinesias in Parkinson's Disease.

Pagano G, Yousaf T, Politis M.

Curr Neurol Neurosci Rep. 2017 Oct 3;17(11):90. doi: 10.1007/s11910-017-0794-2. Review.

36.

Striatal molecular alterations in HD gene carriers: a systematic review and meta-analysis of PET studies.

Niccolini F, Pagano G, Fusar-Poli P, Wood A, Mrzljak L, Sampaio C, Politis M.

J Neurol Neurosurg Psychiatry. 2018 Feb;89(2):185-196. doi: 10.1136/jnnp-2017-316633. Epub 2017 Sep 9. Review.

PMID:
28889093
37.

Chronic exposure to dopamine agonists affects the integrity of striatal D2 receptors in Parkinson's patients.

Politis M, Wilson H, Wu K, Brooks DJ, Piccini P.

Neuroimage Clin. 2017 Aug 24;16:455-460. doi: 10.1016/j.nicl.2017.08.013. eCollection 2017.

38.

Imaging the Nonmotor Symptoms in Parkinson's Disease.

Yousaf T, Wilson H, Politis M.

Int Rev Neurobiol. 2017;133:179-257. doi: 10.1016/bs.irn.2017.05.001. Epub 2017 Jun 7. Review.

PMID:
28802921
39.

Hypertension is associated with worse cognitive function and hippocampal hypometabolism in Alzheimer's disease.

Moonga I, Niccolini F, Wilson H, Pagano G, Politis M; Alzheimer's Disease Neuroimaging Initiative.

Eur J Neurol. 2017 Sep;24(9):1173-1182. doi: 10.1111/ene.13374. Epub 2017 Jul 28.

PMID:
28752644
40.

Loss of phosphodiesterase 4 in Parkinson disease: Relevance to cognitive deficits.

Niccolini F, Wilson H, Pagano G, Coello C, Mehta MA, Searle GE, Gunn RN, Rabiner EA, Foltynie T, Politis M.

Neurology. 2017 Aug 8;89(6):586-593. doi: 10.1212/WNL.0000000000004201. Epub 2017 Jul 12.

PMID:
28701494
41.

Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson's disease: evidence for dopaminergic basis?

Qamar MA, Sauerbier A, Politis M, Carr H, Loehrer P, Chaudhuri KR.

NPJ Parkinsons Dis. 2017 Jan 25;3:5. doi: 10.1038/s41531-016-0006-9. eCollection 2017.

42.

PET image reconstruction using multi-parametric anato-functional priors.

Mehranian A, Belzunce MA, Niccolini F, Politis M, Prieto C, Turkheimer F, Hammers A, Reader AJ.

Phys Med Biol. 2017 Jul 6;62(15):5975-6007. doi: 10.1088/1361-6560/aa7670.

PMID:
28570263
43.

Imaging in Parkinson's Disease.

Politis M, Pagano G, Niccolini F.

Int Rev Neurobiol. 2017;132:233-274. doi: 10.1016/bs.irn.2017.02.015. Epub 2017 Mar 30. Review.

PMID:
28554409
44.

Disease progression in LRRK2 parkinsonism.

Politis M.

Lancet Neurol. 2017 May;16(5):334-335. doi: 10.1016/S1474-4422(17)30082-0. No abstract available.

PMID:
28414642
45.

It is a painful somatic symptom, not the history of cancer/malignancy that is associated with depression: findings from multiple national surveys.

Johnson K, Politis MD, Hansen AR, McKenzie LE, Duncan DT, Zhang J.

Pain. 2017 Apr;158(4):740-746. doi: 10.1097/j.pain.0000000000000826.

PMID:
28301860
46.

Cognitive decline in Parkinson disease.

Aarsland D, Creese B, Politis M, Chaudhuri KR, Ffytche DH, Weintraub D, Ballard C.

Nat Rev Neurol. 2017 Apr;13(4):217-231. doi: 10.1038/nrneurol.2017.27. Epub 2017 Mar 3. Review.

47.

Urinary dysfunction in early de novo patients with Parkinson's disease.

Pagano G, Niccolini F, Yousaf T, Wilson H, Polychronis S, Chaudhuri KR, Politis M.

Mov Disord. 2017 Jun;32(6):939-940. doi: 10.1002/mds.26967. Epub 2017 Mar 3. No abstract available.

PMID:
28256013
48.

Molecular Imaging Markers to Track Huntington's Disease Pathology.

Wilson H, De Micco R, Niccolini F, Politis M.

Front Neurol. 2017 Jan 30;8:11. doi: 10.3389/fneur.2017.00011. eCollection 2017. Review.

49.

Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers.

Strafella AP, Bohnen NI, Perlmutter JS, Eidelberg D, Pavese N, Van Eimeren T, Piccini P, Politis M, Thobois S, Ceravolo R, Higuchi M, Kaasinen V, Masellis M, Peralta MC, Obeso I, Pineda-Pardo JÁ, Cilia R, Ballanger B, Niethammer M, Stoessl JA; IPMDS-Neuroimaging Study Group.

Mov Disord. 2017 Feb;32(2):181-192. doi: 10.1002/mds.26907. Epub 2017 Feb 2. Review.

50.

Gender-based differences in water, sanitation and hygiene-related diarrheal disease and helminthic infections: a systematic review and meta-analysis.

Sevilimedu V, Pressley KD, Snook KR, Hogges JV, Politis MD, Sexton JK, Duke CH, Smith BA, Swander LC, Baker KK, Gambhir M, Fung IC.

Trans R Soc Trop Med Hyg. 2017 Jan 22. doi: 10.1093/trstmh/trw080. [Epub ahead of print] Review.

PMID:
28115686

Supplemental Content

Loading ...
Support Center